Deubiquitinase ubiquitin‐specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells
Q Lu, D Lu, ZM Shao, DQ Li - Cancer science, 2019 - Wiley Online Library
… First, USP9X is a novel binding partner but not a ubiquitinated substrate of E3 … In support
of our findings, USP9X has been shown to regulate the stability of several E3 ubiquitin ligases, …
of our findings, USP9X has been shown to regulate the stability of several E3 ubiquitin ligases, …
E3 ubiquitin ligases in cancer and implications for therapies
… in human breast cancer [127]. On the contrary, another study on breast cancer indicated that
… of breast cancer cells by TGF-β/Smad-mediated epithelial-mesenchymal transition (EMT) […
… of breast cancer cells by TGF-β/Smad-mediated epithelial-mesenchymal transition (EMT) […
A novel signature of CCNF-associated E3 ligases collaborate and counter each other in breast cancer
SC Chang, CS Hung, BX Zhang, TH Hsieh, W Hsu… - Cancers, 2021 - mdpi.com
… To further understand the pathophysiological role of SCF E3 ubiquitin ligase in BRCA, we
… BRCA tissues (n = 60, with 30 breast carcinoma tissues and 30 normal tissue counterparts) (…
… BRCA tissues (n = 60, with 30 breast carcinoma tissues and 30 normal tissue counterparts) (…
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases
K Ito, I Harada, C Martinez, K Sato, EJ Lee, E Port… - Cancer Research …, 2024 - AACR
… E3 ligases (18, 19). In contrast, acetylation of SNAIL prevents its recognition by E3 ubiquitin
ligases … of EMT and metastasis of triple-negative breast cancer (TNBC) cells driven by the …
ligases … of EMT and metastasis of triple-negative breast cancer (TNBC) cells driven by the …
Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56
M Xue, K Zhang, K Mu, J Xu, H Yang, Y Liu, B Wang… - Oncogenesis, 2019 - nature.com
… the E3 ubiquitin ligase TRIM56 as the novel modulator of ER alpha signaling in breast cancer…
Here we report that the RING family ubiquitin ligase TRIM56 associates with and stabilizes …
Here we report that the RING family ubiquitin ligase TRIM56 associates with and stabilizes …
Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187
… ubiquitination and protein stability. Here, we report that RNF187, a RING family ubiquitin
ligase, facilitates breast cancer … Our findings revealed not only a novel E3 ligase regulator of …
ligase, facilitates breast cancer … Our findings revealed not only a novel E3 ligase regulator of …
Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression
… Besides, our microarray data also indicated a few novel pathways affected in breast cancer
cells, including NFκB pathway, TGFβ pathway and Wnt pathway [20]. As p53 wild type tends …
cells, including NFκB pathway, TGFβ pathway and Wnt pathway [20]. As p53 wild type tends …
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
J Zhu, X Li, P Su, M Xue, Y Zang, Y Ding - Oncogene, 2020 - nature.com
… control the ERα signaling activity, is critical for developing novel therapeutics for breast cancer.
… E3 ubiquitin ligase, we further investigate the role of RNF181 on ERα ubiquitination. The …
… E3 ubiquitin ligase, we further investigate the role of RNF181 on ERα ubiquitination. The …
Novel insights into E3 ubiquitin ligase in cancer chemoresistance
L Yang, J Chen, X Huang, E Zhang, J He… - The American journal of the …, 2018 - Elsevier
… containing E3 ubiquitin protein ligase 1 (WWP1) belongs to the HECTD3 E3 ubiquitin ligase
… WWP1 is overexpressed in estrogen receptor α (ERα)-positive breast cancer. Meanwhile, …
… WWP1 is overexpressed in estrogen receptor α (ERα)-positive breast cancer. Meanwhile, …
[HTML][HTML] E3 ubiquitin ligases in breast cancer metastasis: a systematic review of pathogenic functions and clinical implications
Y Wang, J Dai, Y Zeng, J Guo, J Lan - Frontiers in Oncology, 2021 - frontiersin.org
… will be discovered and developed as a novel class of anticancer drugs in the foreseeable
future, we are still facing significant challenges so far. Firstly, the specific substrate of …
future, we are still facing significant challenges so far. Firstly, the specific substrate of …